ACURABIO
AcuraBio is a contract development and manufacturing organization serving the pharmaceutical, biotechnology, and veterinary industries.
ACURABIO
Social Links:
Industry:
Biotechnology Manufacturing Medical Pharmaceutical Veterinary
Founded:
2016-01-01
Address:
Brisbane, Queensland, Australia
Country:
Australia
Website Url:
http://www.acurabio.com
Total Employee:
51+
Status:
Active
Contact:
+61 (07) 3273 9176
Technology used in webpage:
Domain Not Resolving SPF Mobile Non Scaleable Content Person Schema Microsoft Exchange Online Google Office 365 Mail Google Cloud Facebook Sharer Sectigo SSL
Similar Organizations
Admescope
Admescope is a CRO providing the pharmaceutical, biotechnology and veterinary industry with premium quality tailor made services.
Argenta
Argenta is a contract research organization (CRO) and contract manufacturing organization (CMO) specializing in animal health.
Bioinicia
Bioinicia focuses on contract development and contract manufacturing of electrospun products for pharmaceutical and medical applications.
Bioserv
Bioserv is a contract manufacturing organization that serves the pharmaceutical industry.
Cell Therapies
Cell Therapies is a contract development and manufacturing organization that manufactures and distributes cell-based therapies.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Current Employees Featured
Official Site Inspections
http://www.acurabio.com Semrush global rank: 8.87 M Semrush visits lastest month: 455
- Host name: 255.178.168.34.bc.googleusercontent.com
- IP address: 34.168.178.255
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AcuraBio"
AcuraBio closes a year after PE takeover - BioProcess Insider
Sep 12, 2023 · According to a notice published on the Australian Securities & Investments Commission (ASIC), contract development and manufacturing organization (CDMO) AcuraBio …See details»
AcuraBio - Crunchbase Company Profile & Funding
AcuraBio is a contract development and manufacturing organization serving the pharmaceutical, biotechnology, and veterinary industries. AcuraBio may be growing as it has expanded its …See details»
Dr. Glenn Haifer and Ampersand Capital Partners Acquire …
Brisbane, Australia – 30 August 2022 – AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and …See details»
Luina Bio Acquisition Announcement | BioMelbourne Network
Sep 1, 2022 · Brisbane, Australia – 31 August 2022 – AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer …See details»
Dr. Glenn Haifer and Ampersand Capital Partners Acquire …
BRISBANE, Australia, Sept. 7, 2022 /PRNewswire/ -- AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer …See details»
Dr. Glenn Haifer and Ampersand Capital Partners …
Aug 30, 2022 · AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global healthcare private equity firm.See details»
Private equity group and biotech investor acquire Australian …
Sep 1, 2022 · Luina Bio, an Australian biopharmaceutical CDMO, has been acquired by a biotech investor and a private equity group, namely Dr Glenn Haifer and Ampersand Capital Partners. …See details»
Dr. Glenn Haifer and Ampersand Capital Partners …
Sep 1, 2022 · AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global healthcare private equity firm.See details»
Aussie CDMO AcuraBio acquired by Ampersand and Dr Haifer
Aug 30, 2022 · AcuraBio (formerly Luina Bio), an Australian biopharma contract development and manufacturing organization (CDMO), has been acquired by biotech investor Dr Glenn Haifer …See details»
AcuraBio - Products, Competitors, Financials, Employees, …
About AcuraBio. AcuraBio is a contract development and manufacturing organization (CDMO) offering early-phase pharmaceutical manufacturing services including process development …See details»
AcuraBio Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, acquisitions, investors, and executives for AcuraBio. Use the PitchBook Platform to explore the full profile.See details»
Dr. Glenn Haifer and Ampersand Capital Partners Acquire …
Sep 22, 2001 · BRISBANE, Australia – AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and …See details»
Acquisition Signifies Increased Biopharma Provisions for the APAC ...
Leading Australian biopharmaceutical CDMO, AcuraBio (formerly Luina Bio), has been acquired by biotech investor Dr Glenn Haifer and Ampersand Capital Partners, a global healthcare …See details»
AcuraBio - Overview, News & Similar companies | ZoomInfo.com
Feb 10, 2023 · Who is AcuraBio. AcuraBio is an Australia-based contract development and manufacturing organization (CDMO) that provides development and biomanufacturing to the …See details»
Dr. Glenn Haifer and Ampersand Capital Partne | EurekAlert!
Sep 7, 2022 · AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global …See details»
AcuraBio expands cGMP plasmid DNA CDMO services with …
BRISBANE, Australia, Feb. 10, 2023 /PRNewswire/ — AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organization (CDMO), will provide …See details»
Dr. Glenn Haifer and Ampersand Capital Partners Acquire …
BRISBANE, AUS, Aug 30, 2022 - (ACN Newswire) - AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer …See details»
AcuraBio expands cGMP plasmid DNA CDMO services with …
Feb 8, 2023 · AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organization (CDMO), will provide a cGMP plasmid DNA CDMO service to the …See details»
AcuraBio expands cGMP plasmid DNA CDMO services with …
BRISBANE, Australia, Feb. 10, 2023 /PRNewswire/ -- AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organization (CDMO), will provide …See details»